Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionSilvercrest Asset Management Group Llc
Latest Disclosed Ownership25,960 shares
Latest Disclosed Value $ 3,618,078
Silvercrest Asset Management Group Llc reports 3.26% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Silvercrest Asset Management Group Llc filed a 13F-HR form disclosing ownership of 25,960 shares of Gilead Sciences, Inc. (US:GILD) valued at $3,618,045 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 26,836 shares of Gilead Sciences, Inc.. This represents a change in shares of -3.26% during the quarter. The current value of the position is $3,348,580 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES INC COM COM 375558103 25,960 -876 -3.26 3,618 9.87 0.0261
2026-02-17 2025-12-31 13F GILEAD SCIENCES INC COM COM 375558103 26,836 6,299 30.67 3,294 44.49 0.0226
2025-11-14 2025-09-30 13F GILEAD SCIENCES INC COM COM 375558103 20,537 61 0.30 2,280 0.40 0.0151
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 20,476 -564 -2.68 2,270 -3.69 0.0153
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 21,040 4,017 23.60 2,358 49.94 0.0169
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 17,023 0 0.00 1,572 10.16 0.0105
2024-11-14 2024-09-30 13F GILEAD SCIENCES INC COM COM 375558103 17,023 0 0.00 1,427 22.28 0.0097
2024-08-15 2024-06-30 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 17,023 0 0.00 1,168 -6.34 0.0080
2024-08-14 2024-06-30 13F GILEAD SCIENCES INC COM COM 375558103 34,046 17,023 2,336 0.0053
2024-05-15 2024-03-31 13F GILEAD SCIENCES INC COM COM 375558103 17,023 -27 -0.16 1,247 -9.78 0.0084
2024-02-14 2023-12-31 13F GILEAD SCIENCES INC COM COM 375558103 17,050 516 3.12 1,381 11.46 0.0098
2023-11-14 2023-09-30 13F GILEAD SCIENCES INC COM COM 375558103 16,534 -100 -0.60 1,239 -3.28 0.0094
2023-08-14 2023-06-30 13F GILEAD SCIENCES INC COM COM 375558103 16,634 225 1.37 1,282 -5.88 0.0091
2023-05-15 2023-03-31 13F GILEAD SCIENCES INC COM COM 375558103 16,409 -70 -0.42 1,361 -3.75 0.0103
2023-02-14 2022-12-31 13F GILEAD SCIENCES INC COM COM 375558103 16,479 73 0.44 1,415 39.72 0.0109
2022-11-14 2022-09-30 13F GILEAD SCIENCES INC COM COM 375558103 16,406 -170 -1.03 1,012 -1.27 0.0083
2022-08-15 2022-06-30 13F GILEAD SCIENCES INC COM COM 375558103 16,576 -200 -1.19 1,025 2.81 0.0078
2022-05-16 2022-03-31 13F GILEAD SCIENCES INC COM COM 375558103 16,776 -1,028 -5.77 997 -22.89 0.0065
2022-02-14 2021-12-31 13F GILEAD SCIENCES INC COM COM 375558103 17,804 -622 -3.38 1,293 0.47 0.0082
2021-11-15 2021-09-30 13F GILEAD SCIENCES INC COM COM 375558103 18,426 -74 -0.40 1,287 1.02 0.0087
2021-08-16 2021-06-30 13F GILEAD SCIENCES INC COM COM 375558103 18,500 -250 -1.33 1,274 5.12 0.0084
2021-05-17 2021-03-31 13F GILEAD SCIENCES INC COM COM 375558103 18,750 -4,551 -19.53 1,212 -10.75 0.0082
2021-02-16 2020-12-31 13F GILEAD SCIENCES INC COM COM 375558103 23,301 -1,294 -5.26 1,358 -12.61 0.0099
2020-11-16 2020-09-30 13F GILEAD SCIENCES INC COM COM 375558103 24,595 -1,462 -5.61 1,554 -22.49 0.0133
2020-08-14 2020-06-30 13F GILEAD SCIENCES INC COM COM 375558103 26,057 -440 -1.66 2,005 1.21 0.0178
2020-05-15 2020-03-31 13F GILEAD SCIENCES INC COM COM 375558103 26,497 -5,164 -16.31 1,981 -3.69 0.0212
2020-02-14 2019-12-31 13F GILEAD SCIENCES INC COM COM 375558103 31,661 1,250 4.11 2,057 6.75 0.0160
2019-11-14 2019-09-30 13F GILEAD SCIENCES INC COM COM 375558103 30,411 -2,200 -6.75 1,927 -12.53 0.0159
2019-08-14 2019-06-30 13F GILEAD SCIENCES INC COM COM 375558103 32,611 -5,080 -13.48 2,203 -10.08 0.0206
2019-05-15 2019-03-31 13F GILEAD SCIENCES INC COM COM 375558103 37,691 -2,237 -5.60 2,450 -1.92 0.0241
2019-02-14 2018-12-31 13F GILEAD SCIENCES INC COM COM 375558103 39,928 -220 -0.55 2,498 -19.42 0.0275
2018-11-14 2018-09-30 13F GILEAD SCIENCES INC COM COM 375558103 40,148 -1,623 -3.89 3,100 4.77 0.0281
2018-08-14 2018-06-30 13F GILEAD SCIENCES INC COM COM 375558103 41,771 -8,705 -17.25 2,959 -22.23 0.0277
2018-05-15 2018-03-31 13F GILEAD SCIENCES INC COM COM 375558103 50,476 3,455 7.35 3,805 12.94 0.0371
2018-02-14 2017-12-31 13F GILEAD SCIENCES INC COM COM 375558103 47,021 2,516 5.65 3,369 -6.57 0.0313
2017-11-14 2017-09-30 13F GILEAD SCIENCES INC COM COM 375558103 44,505 600 1.37 3,606 16.02 0.0359
2017-08-14 2017-06-30 13F GILEAD SCIENCES INC COM COM 375558103 43,905 -302 -0.68 3,108 3.53 0.0333
2017-05-15 2017-03-31 13F GILEAD SCIENCES INC COM COM 375558103 44,207 -3,793 -7.90 3,002 -12.66 0.0321
2017-02-14 2016-12-31 13F GILEAD SCIENCES INC COM COM 375558103 48,000 255 0.53 3,437 -9.03 0.0385
2016-11-14 2016-09-30 13F GILEAD SCIENCES INC COM COM 375558103 47,745 -2,428 -4.84 3,778 -9.73 0.0454
2016-08-15 2016-06-30 13F GILEAD SCIENCES INC COM COM 375558103 50,173 580 1.17 4,185 -8.14 0.0532
2016-05-16 2016-03-31 13F GILEAD SCIENCES INC COM COM 375558103 49,593 -74 -0.15 4,556 -9.35 0.0628
2016-02-16 2015-12-31 13F GILEAD SCIENCES INC COM COM 375558103 49,667 3,341 7.21 5,026 10.49 0.0696
2015-11-16 2015-09-30 13F GILEAD SCIENCES INC COM COM 375558103 46,326 14,833 47.10 4,549 23.38 0.0692
2015-08-14 2015-06-30 13F GILEAD SCIENCES INC COM COM 375558103 31,493 8,041 34.29 3,687 60.23 0.0493
2015-05-15 2015-03-31 13F GILEAD SCIENCES INC COM COM 375558103 23,452 4,750 25.40 2,301 30.52 0.0327
2015-02-17 2014-12-31 13F GILEAD SCIENCES INC COM COM 375558103 18,702 1,900 11.31 1,763 -1.45 0.0256
2014-11-14 2014-09-30 13F GILEAD SCIENCES INC COM COM 375558103 16,802 -300 -1.75 1,789 26.16 0.0276
2014-08-14 2014-06-30 13F GILEAD SCIENCES INC COM COM 375558103 17,102 1,702 11.05 1,418 29.97 0.0213
2014-05-15 2014-03-31 13F GILEAD SCIENCES INC COM COM 375558103 15,400 -374 -2.37 1,091 -7.93 0.0174
2014-02-14 2013-12-31 13F GILEAD SCIENCES INC COM COM 375558103 15,774 -50 -0.32 1,185 19.10 0.0197
2013-11-14 2013-09-30 13F GILEAD SCIENCES INC COM COM 375558103 15,824 -250 -1.56 995 20.75 0.0191
2013-08-14 2013-06-30 13F GILEAD SCIENCES INC COM COM 375558103 16,074 16,074 824 0.0174
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.